Norris Medicines Ltd — Important, 04-02-2026: Company Update

Norris Medicines announced that Mr. Iqubal Patel has resigned as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) due to personal reasons, effective February 03, 2026. This change impacts the company's financial leadership and oversight. The company is actively seeking a replacement for the CFO position, and the board will formally record his resignation at an upcoming meeting. A new CFO appointment will be communicated in due course, ensuring continuity in financial management.